arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Microbot Medical Inc.

MBOT

$1.89 ▲ +0.09 (+5.00%) at close

18 Visible periods

26 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Neutral

auto_awesome

Analytical Summary

Microbot Medical Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $86.5M

Dividend Yield —

Revenue Growth None

Op. Margin —

ROIC -15.0% ↗

FCF / Share $-0.29 ↗

Trailing P/E —

Price / Book 1.6x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$116.89K

↓ -88.5% —

Net Income Profit after all expenses

$-13.14M

↓ -14.8% —

FCF / Share Free cash flow per share

$-0.29

↑ +49.4% —

Long-Term Debt Long-term obligations

$125.00K

↓ -62.3% —

Health Breakdown

Returns ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	—	—	—	—	-88.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1206%)	-15.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-298%)	-12.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-250%)	12.1% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+51%)	-14.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-281%)	43.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+447%)	—	—
EPS Growth YoY (%)	60.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	30.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	42.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-13.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-14.8% Weak ↓ Weak Declining Year-over-year change in net income	-6.5% Weak ↑ Weak Improving Year-over-year change in net income	18.4% Good ↑ Good Improving Year-over-year change in net income	-16.4% Weak → Weak Stable Year-over-year change in net income	-23.4% Weak ↓ Weak Declining Year-over-year change in net income	-26.5% Weak ↓ Weak Declining Year-over-year change in net income	-0.1% Weak ↓ Weak Declining Year-over-year change in net income	4.6% Caution ↓ Caution Declining Year-over-year change in net income	21.5% Good ↑ Good Improving Year-over-year change in net income	73.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-11.2% Weak ↑ Weak Improving Year-over-year change in net income	-23.8% Weak ↓ Weak Declining Year-over-year change in net income	7.2% Fair ↑ Fair Improving Year-over-year change in net income	-33.6% Weak ↓ Weak Declining Year-over-year change in net income	15.5% Good Good Year-over-year change in net income	6.6% Fair Fair Year-over-year change in net income	—	—
FCF Growth YoY (%)	49.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	32.6% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	47.6% Excellent Excellent Year-over-year change in free cash flow	-20.9% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	—	—	—	—	-56.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-6.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-5.5% Weak Weak Compound annual revenue growth over 3 years	11.3% Good Good Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	—	—	—	—	—	—	—	—	—	—	-39.4% Weak Weak Compound annual revenue growth over 5 years	0.4% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
FCF / Net Income (x)	1.00x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.08x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.06x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.70x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Return on Invested Capital (%)	-15.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-260.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-173.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-143.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-62.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	432.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	41.8% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	-448.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	8679.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-415.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-151.1% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-126.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-200.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-144.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-76.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-18.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-192.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-118.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-139.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-67.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	118.9% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	47.8% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-286.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-173.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-95.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-68.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-74.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-111.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-95.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-16.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-213%)	—	-238.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1691%)	-180.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1304%)	-78.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-624%)	-37.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-351%)	-23.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-253%)	—	-76.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-608%)	—	—	—	-176.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1279%)	-203.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1458%)	-198.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1426%)	-163.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1187%)	-88.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-691%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	0.01x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-99%)	0.03x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-95%)	0.03x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-94%)	—	—
Interest Coverage (x)	—	-67.98x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-75.81x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-260.41x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11357.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-284.03x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-74.64x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	22.22x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-28.93x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-72.52x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-23.86x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-24.52x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-449.18x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-393.43x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-314.40x Weak Weak Operating income divided by interest expense Optimal: > 5x	-265.13x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-3.91M	$-3.11M	$-2.47M	$-2.44M	$-13.49M	$-19.65M	$-28.77M	$-5.24M	$-10.79M	$-2.71M	$-12.11M	$-24.99M	$-30.59M	$-8.35M	$-12.98M	$-19.19M	$-38.62M	$-30.04M
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.01x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.01x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.02x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Basic EPS, GAAP (USD)	$-0.29	$-0.73	$-1.05	$-1.81	$-1.59	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.29	$-0.57	$-0.84	$-1.60	$-1.33	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$1.15	$0.18	$0.38	$0.92	$2.02	$3.42	$4.39	$0.44	$4.95	$0.11	$-0.00	$0.09	$3.27	$4.49	$5.76	$14.65	—	—
Tangible Book Value per Share (USD)	$1.15	$0.18	$0.38	$0.92	$2.02	$3.42	$4.39	$0.44	$4.95	$0.11	$-0.00	$0.08	$2.40	$3.27	$3.66	$10.04	—	—
Basic Weighted Avg Shares (shares)	45.79M	15.64M	10.20M	7.26M	7.11M	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Working Capital (USD)	$76.40M	$3.36M	$4.13M	$6.75M	$13.89M	$23.91M	$31.11M	$1.07M	$10.40M	$2.53M	$5.38M	$15.01M	$22.71M	$18.94M	$11.74M	$15.64M	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	$125.00K	$331.25K	$522.50K	—	—
Total Equity (USD)	$77.55M	$3.53M	$4.50M	$7.29M	$14.38M	$24.31M	$31.54M	$1.32M	$9.96M	$1.70M	$-334.21K	$5.87M	$14.95M	$13.98M	$10.73M	$15.48M	$30.50M	$21.81M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	—	$116.89K	$1.01M	$1.20M	$1.37M	$1.22M	$1.43M	$992.87K	—
Depreciation Expense (USD)	$47.00K	$91.00K	$106.00K	$102.00K	$76.00K	$68.00K	$84.00K	$54.00K	$21.00K	$10.00K	$1.13M	$1.31M	$1.06M	$991.72K	$1.21M	$1.52M	$1.69M	—
Net Income, GAAP (USD)	$-13.14M	$-11.44M	$-10.74M	$-13.17M	$-11.31M	$-9.17M	$-7.25M	$-7.24M	$-7.59M	$-9.66M	$-36.42M	$-32.74M	$-26.44M	$-28.49M	$-21.33M	$-25.24M	$-27.03M	—
Operating Cash Flow (USD)	$-13.05M	$-8.83M	$-8.53M	$-11.55M	$-9.35M	$-7.25M	$-6.45M	$-5.31M	$-4.86M	$-786.00K	$-30.68M	$-27.35M	$-23.32M	$-19.87M	$-22.06M	$-24.52M	$-24.68M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters

Microbot Medical Inc.

Analytical Summary

18-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare MBOT with peers